Global Induced Pluripotent Stem Cell Market, Size, Trends & Analysis - Forecasts To 2026 By Technology (Cell Acquisition Technology, Cell Production, Others), By Product (Adult Stem Cells, HESC), By Therapy (Allogeneic & Autologous, Others), By Application (Regenerative Medicine, Drug Discovery & Development, Neurology), By Region (North America, Europe, Asia Pacific, CSA, MEA); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

Global Induced Pluripotent Stem Cell Market, Size, Trends & Analysis - Forecasts To 2026 By Technology (Cell Acquisition Technology, Cell Production, Others), By Product (Adult Stem Cells, HESC), By Therapy (Allogeneic & Autologous, Others), By Application (Regenerative Medicine, Drug Discovery & Development, Neurology), By Region (North America, Europe, Asia Pacific, CSA, MEA); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

  • Published Date: June 11 : 2020
  • Base Year for Estimate: 2019
  • Report Id:2070

Induced Pluripotent Stem Cell Market: Insights

The global induced pluripotent stem cells (iPSCs) market is estimated to witness a significant CAGR during the forecast period (2020-2026). Induced pluripotent stem cells (iPSCs or iPS cells) are a form of pluripotent stem cells, generated directly from somatic (adult) cells. Pluripotent stem cells have significant potential in regenerative medicine. Automation in the adult stem cell and cord blood processing and storage are the key technologies expected to positively impact the growth of the adult cord blood stem cells market. However, factors such as increasing costs associated with the treatment and reprogramming of cells, lengthy processes, and ethical issues, along with low efficiency and proliferation rates, possible tumor risk, premature cell death, and incomplete programming are some of the factors hampering the market growth.

Induced Pluripotent Stem Cell Market: By Product

Based on the product type, the market is segmented into adult stem cells and HESC. The adult stem cells are projected to hold the largest market share during the forecast period due to the growing availability of low contamination risk associated with sub-culturing, compatibility with the human body, and minimal requirement of production labor drives the productive growth of the market. Benefits of adult stem cell such as the capacity for autologous transformation, low risk of tumor formation, and availability of established treatment is expected to drive the market growth.

Induced Pluripotent Stem Cell Market: By Application

Based on application, the market is segmented into regenerative medicine, neurology, and drug discovery & development, among others. Regenerative medicine is projected to dominate the largest market share during the forecast period. The rising adoption and ongoing development of companion diagnostics and personalized medicine for usage in oncology and other chronic drives the growth of the market.

Induced Pluripotent Stem Cell Market: By Technology

Based on technology, the market is segmented into cell acquisition technology, and cell production among others. Cell acquisition technology is expected to hold the largest market share during the forecast period due to growing awareness about the significance of stem cells which has led to significant growth in the cell harvesting.

Induced Pluripotent Stem Cell Market: By Therapy

Based on therapy, the market is segmented into allogeneic therapy autologous therapy, and others. Allogeneic therapy is anticipated to dominate the large market share during the forecast period due to the availability of treatment or prevention of cancer relapse. Autologous therapy is projected to grow at a high CAGR during the forecast period due to the low risk of complications associated with autologous treatment.

Induced Pluripotent Stem Cell Market

Induced Pluripotent Stem Cell Market: By Region

Based on region, the global induced pluripotent stem cell market is segmented into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. North America is projected to dominate a large market share during the forecast period due to the lack of human samples and researchers relied on immortalized cell-based assays or in-vivo animal models for clinical trials and research. The growing presence of major biotechnology companies, extensive government funding, and increasing research in the area of pharmaceuticals also drives the growth of the market. In Europe, research and development operations in contract research organization sector and other clinical services, outsourcing of iPSCs trials has eventually bolstered the process of drug approval, which drives the lucrative growth of the market. The Asia-Pacific region is expected to witness rapid growth due to the increasing number of research projects in countries such as Japan, Singapore, and Australia which in turn is anticipated to propel the market growth.

Induced Pluripotent Stem Cell Market: Share & Competitor Analysis

Some of the key players operating in the induced pluripotent stem cell market include: Allele Biotechnology and Pharmaceuticals Inc., Applied Stemcell Inc., ABAM (Applied Biological Materials Inc.), Addgene, Cell Signaling Technology, Cellular Dynamics International, EMD Millipore, Astellas Pharma Inc., Bluerock Therapeutics, Bristol-Myers Squibb (Ipierian), EVOTEC, Japan Tissue Engineering Co., Ltd., ViaCyte, Inc., Fate Therapeutics, FUJIFILM Holdings Corporation, GenTarget, Inc, Merck/Sigma Aldrich, ORIG3N, Century Therapeutics, LLC, Vericel Corporation, BioCat GmbH, Beckman Coulter Life Sciences, and ID Pharma Co. Ltd., among others.

Please note: This is not an exhaustive list of companies profiled in the report.

  • In January 2020, Bristol Myers Squibb announced the  commercial launch of ZEPOSIA® (ozanimod), a new oral treatment for relapsing forms of multiple sclerosis
  • In January 2020, Allele Biotechnology and Pharmaceuticals Inc., entered into a licensing agreement with Astellas Pharma Inc. to expand induced pluripotent stem cell (iPSC) technologies for various cell therapy programs

Induced Pluripotent Stem Cell Market: By Technology

  1. Introduction   
    1. Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)        
  2. Cell Acquisition Technology    
    1. Cell Acquisition Technology: Induced Pluripotent Stem Cell Market, 2020-2026 (USD Million)
  3. Cell Production          
    1. Cell Production: Induced Pluripotent Stem Cell Market, 2020-2026 (USD Million)
  4. Others
    1. Others: Induced Pluripotent Stem Cell Market, 2020-2026 (USD Million)

Induced Pluripotent Stem Cell Market: By Product

  1. Introduction   
    1. Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)  
  2. Adult Stem Cells        
    1. Adult Stem Cells: Induced Pluripotent Stem Cell Market, 2020-2026 (USD Million)     
  3. HESC 
    1. HESC: Induced Pluripotent Stem Cell Market, 2020-2026 (USD Million)

Induced Pluripotent Stem Cell Market: By Therapy

  1. Introduction   
    1. Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million) 
  2. Allogeneic & Autologous        
    1. Allogeneic & Autologous: Induced Pluripotent Stem Cell Market, 2020-2026 (USD Million)     
  3. Others
    1. Others: Induced Pluripotent Stem Cell market, 2020-2026 (USD Million)

Induced Pluripotent Stem Cell Market: By Application

  1. Introduction   
    1. Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)        
  2. Regenerative Medicine          
    1. Regenerative Medicine: Induced Pluripotent Stem Cell Market, 2020-2026 (USD Million)       
  3. Drug Discovery & Development         
    1. Drug Discovery & Development: Induced Pluripotent Stem Cell Market, 2020-2026 (USD Million)
  4. Neurology      
    1. Neurology : Induced Pluripotent Stem Cell Market, 2020-2026 (USD Million)

Induced Pluripotent Stem Cell Market: By Region

  1. Introduction   
    1. Global Induced Pluripotent Stem Cell Market, Regional Analysis, 2020-2026 (USD Million)     
  2. North America
    1. North America Induced Pluripotent Stem Cell Market, Regional Analysis, 2020-2026 (USD Million)   
      1. By Technology 
        1. North America Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)  
      2. By Product      
        1. North America Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)           
      3. By Therapy      
        1. North America Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)           
      4. By Application 
        1. North America Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)  
      5. By Country      
        1. U.S      
          1. By Technology 
            1. U.S Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)      
          2. By Product      
            1. U.S Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)      
          3. By Therapy      
            1. U.S Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)      
          4. By Application 
            1. U.S Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)      
        2. Canada.          
          1. By Technology 
            1. Canada Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)         
          2. By Product      
            1. Canada Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)         
          3. By Therapy      
            1. Canada Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)         
          4. By Application 
            1. Canada Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)         
        3. Mexico
          1. By Technology 
            1. Mexico Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)         
          2. By Product      
            1. Mexico Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)      
          3. By Therapy      
            1. Mexico Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)                     
          4. By Application 
            1. Mexico Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
  3. Europe           
    1. Europe Induced Pluripotent Stem Cell Market, Regional Analysis, 2020-2026 (USD Million)   
      1. By Technology 
        1. Europe Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)           
      2. By Product      
        1. Europe Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)           
      3. By Therapy      
        1. Europe Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)           
      4. By Application 
        1. Europe Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
      5. By Country      
        1. Germany         
          1. By Technology 
            1. Germany Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)         
          2. By Product      
            1. Germany Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)         
          3. By Therapy      
            1. Germany Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)                     
          4. By Application 
            1. Germany Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
        2. UK       
          1. By Technology 
            1. UK Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)      
          2. By Product      
            1. UK Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)      
          3. By Therapy      
            1. UK Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)      
          4. By Application 
            1. UK Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)      
        3. France
          1. By Technology 
            1. France Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)         
          2. By Product      
            1. France Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)      
          3. By Therapy      
            1. France Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)                  
          4. By Application 
            1. France Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
        4. Italy     
          1. By Technology 
            1. Italy Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)         
          2. By Product      
            1. Italy Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)      
          3. By Therapy      
            1. Italy Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)      
          4. By Application 
            1. Italy Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)         
        5. Rest Of Europe
          1. By Technology 
            1. Rest Of Europe Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)  
          2. By Product      
            1. Rest Of Europe Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)
          3. By Therapy      
            1. Rest Of Europe Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)            
          4. By Application 
            1. Rest Of Europe Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
  4. Asia Pacific    
    1. Asia Pacific Induced Pluripotent Stem Cell Market, Regional Analysis, 2020-2026 (USD Million)   
      1. By Technology 
        1. Asia Pacific Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)           
      2. By Product      
        1. Asia Pacific Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)           
      3. By Therapy      
        1. Asia Pacific Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)
      4. By Application 
        1. Asia Pacific Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)                       
      5. By Country      
        1. China  
          1. By Technology 
            1. China Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)         
          2. By Product      
            1. China Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)      
          3. By Therapy      
            1. China Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)                  
          4. By Application 
            1. China Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
        2. Japan  
          1. By Technology 
            1. Japan Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)         
          2. By Product      
            1. Japan Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)      
          3. By Therapy      
            1. Japan Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)      
          4. By Application 
            1. Japan Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
        3. India   
          1. By Technology 
            1. India Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)         
          2. By Product      
            1. India Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)      
          3. By Therapy      
            1. India Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)      
          4. By Application 
            1. India Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)         
        4. South Korea   
          1. By Technology 
            1. South Korea Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)
          2. By Product      
            1. South Korea Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)         
          3. By Therapy      
            1. South Korea Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)                     
          4. By Application 
            1. South Korea Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
  5. Central & South America       
    1. Central & South America Induced Pluripotent Stem Cell Market, Regional Analysis, 2020-2026 (USD Million)       
      1. By Technology 
        1. Central & South America Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)       
      2. By Product      
        1. Central & South America Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)    
      3. By Therapy      
        1. Central & South America Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)    
      4. By Application 
        1. Central & South America Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
      5. By Country      
        1. Brazil   
          1. By Technology 
            1. Brazil Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)         
          2. By Product      
            1. Brazil Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)      
          3. By Therapy      
            1. Brazil Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)                  
          4. By Application 
            1. Brazil Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
  6. Middle East & Africa  
    1. Middle East & Africa Induced Pluripotent Stem Cell Market, Regional Analysis, 2020-2026 (USD Million)    
      1. By Technology 
        1. Middle East & Africa Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)    
      2. By Product      
        1. Middle East & Africa Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)  
      3. By Therapy      
        1. Middle East & Africa Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)  
      4. By Application 
        1. Middle East & Africa Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)    
      5. By Country      
        1. Saudi Arabia   
          1. By Technology 
            1. Saudi Arabia Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)
          2. By Product      
            1. Saudi Arabia Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)         
          3. By Therapy      
            1. Saudi Arabia Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)            
          4. By Application 
            1. Saudi Arabia Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)
        2. UAE     
          1. By Technology 
            1. UAE Induced Pluripotent Stem Cell Market, By Technology, 2020-2026 (USD Million)         
          2. By Product      
            1. UAE Induced Pluripotent Stem Cell Market, By Product, 2020-2026 (USD Million)      
          3. By Therapy      
            1. UAE Induced Pluripotent Stem Cell Market, By Therapy, 2020-2026 (USD Million)      
          4. By Application 
            1. UAE Induced Pluripotent Stem Cell Market, By Application, 2020-2026 (USD Million)

The global Induced Pluripotent Stem Cell Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

Induced Pluripotent Stem Cell Market

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Induced Pluripotent Stem Cell Market.

Induced Pluripotent Stem Cell Market

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Induced Pluripotent Stem Cell Market

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.

Induced Pluripotent Stem Cell Market

To request a free sample copy of this report, please complete the form below

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy
Request A Free Sample Report
Request For Customization

 

What questions do you have? Get quick response from our industry experts. Request a Free Consultation